| Document Date: 2015-03-23 14:10:41
Open Document File Size: 266,29 KBShare Result on Facebook
Company National Radiotherapy Advisory Group / Leukaemia Group / 3M / / Continent Europe / / Country France / United Kingdom / / IndustryTerm high-energy proton treatment / body site / paediatric cancer services / Cancer Treatment / high-energy proton beams / imaging / clinical protocols / / MedicalCondition cancers / Adult (TYA) cancers / Meningioma / rare adults cancers / solid tumours / Pineoblastoma / cancer / lymphoma / disease / very rare cancer-like diseases / rare cancers / embryonal tumours / Pituitary Adenoma / different rare cancers / metastasis / childhood cancers / TYA cancers / TYA cancer / Soft Tissue Sarcomas / Adult (TYA) Cancer / Esthesioneuroblastoma / tumour / Children’s Cancer / brain tumours / childhood cancer / second malignancy / epithelial tumours / leukaemia / certain cancers / Sarcoma / rare paediatric cancers / selected cancers / lung disease / bone sarcoma / adult cancers / modern curative TYA cancer / appropriate TYA Cancer / paediatric cancer / Craniopharyngioma / different cancer / Juvenile Angiofibroma / second cancers / Cancer-like disease / commoner cancers / tumours / Rhabdomyosarcoma / / MedicalTreatment clinical protocols / chemotherapy / radiotherapy / surgery / / Organization UK PBT National Service / American Society for Therapeutic Radiology and Oncology / NHS / / Position General / / Technology chemotherapy / specific clinical protocols / /
SocialTag |
Clinical Commissioning Policy: Proton Beam Radiotherapy (High Energy) for Teenage and Young Adult Cancer Treatment Clinical Commissioning Policy: Proton Beam